Patient#	Sample#	ASAP2/amphiphysin II:(ARF6/GTP, active),	Ca2+:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	Choline:(Phosphatidylcholine, active),	Exocyst:(ARF6/GTP, active),	GDP:(Dynamin 2/GDP, active),(GTP, active),	Integrin beta 1-Integrin alpha:(ARF6/GTP, active),	clathrin-independent pinocytosis:(ARF6/GTP, active),	cell adhesion mediated by integrin:(Integrin beta 1-Integrin alpha, active),	receptor recycling:(ARF6/GTP, active),(Integrin beta 1-Integrin alpha, active),	substrate adhesion-dependent cell spreading:(Exocyst, active),	CPE:(ARF6/GTP, active),(CPE, protein),	CTNND1:(CTNND1, protein),(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	EDNRB:(EDNRB, protein),	IL2RA:(IL2RA, protein),	KLC1:(KLC1, protein),	MAPK8IP3:(MAPK8IP3, protein),	NME1:(ARF6/GTP, active),(NME1, protein),	SCAMP2:(SCAMP2, protein),	SPAG9:(SPAG9, protein),	TSHR:(ARF6/GTP, active),(TSHR, protein),	VAMP3:(ARF6/GTP, active),(VAMP3, protein),	ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex:(ARF6/GTP, active),(Dynactin Complex, active),(SPAG9, active),	ARF6/GTP/JIP3:(ARF6/GTP, active),(MAPK8IP3, active),	CTNNA1:(CTNNA1, protein),(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	PLD1-2:(ARF6/GTP, active),(PLD1-2, protein),(RALA/GTP, active),(SCAMP2, active),(growth hormone secretagogue receptor activity, active),	endocytosis:(ASAP2/amphiphysin II, active),(IL2RA, active),	positive regulation of endocytosis:(ARF6/GTP, active),(EDNRB, active),	positive regulation of phagocytosis:(VAMP3, active),	ACAP1:(ACAP1, protein),(PLD1-2, active),	Dynamin 2/GTP:(Dynamin 2/GDP, active),(GTP, active),(NME1, active),	JIP4/KLC1:(ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex, active),(KLC1, active),(SPAG9, active),	Phosphatidic acid:(PLD1-2, active),(Phosphatidylcholine, active),	membrane fusion:(PLD1-2, active),	E-cadherin/beta catenin:(Dynamin 2/GTP, active),(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	PIP5K1C:(ARF6/GTP, active),(Ca2+, active),(PIP5K1C, protein),(Phosphatidic acid, active),	Receptors internalized by ARF6 CIE:(ARF6/GDP, active),(Phosphatidic acid, active),(Receptors internalized by ARF6 CIE, protein),(clathrin-independent pinocytosis, active),	PI-4-5-P2:(PI-4-P, active),(PIP5K1C, active),	regulation of calcium-dependent cell-cell adhesion:(E-cadherin/beta catenin, active),	AP-2 adaptor complex:(ARF6/GTP, active),(PI-4-5-P2, active),	CLTC:(ARF6/GDP, active),(CLTC, protein),(PI-4-5-P2, active),	INS:(INS, protein),(PI-4-5-P2, active),(membrane depolarization, active),	calcium ion-dependent exocytosis:(PI-4-5-P2, active),(PLD1-2, active),	clathrin coat assembly:(AP-2 adaptor complex, active),(CLTC, active),	ADRB2:(ADRB2, protein),(clathrin coat assembly, active),	AVPR2:(AVPR2, protein),(clathrin coat assembly, active),	GLUT4/clathrin heavy chain/ACAP1	SLC2A4:(GLUT4/clathrin heavy chain/ACAP1, active),(SLC2A4, protein),	clathrin heavy chain/ACAP1:(GLUT4/clathrin heavy chain/ACAP1, active),	
